Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
COX6CP5, or cytochrome c oxidase subunit 6C pseudogene 5, is classified as a processed pseudogene in the human genome. Unlike its parental gene (COX6C), which codes for a functional component of the mitochondrial cytochrome c oxidase complex involved in the electron transport chain and cellular respiration, COX6CP5 does not encode a functional protein. Pseudogenes, such as COX6CP5, typically arise from duplications or retrotransposition events, resulting in gene copies that have lost protein-coding potential due to accumulated mutations. While some pseudogenes exhibit regulatory RNA functions, there is currently no published evidence that COX6CP5 itself has such activity or involvement in disease processes. Thus, COX6CP5 is not a therapeutic target, nor does it have known drug interactions, clinical biomarker utility, or associated safety concerns.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome c oxidase subunit 6C pseudogene 5 (COX6CP5).